Advisory Services Network’s Recursion Pharmaceuticals RXRX Stock Holding History

Advisory Services Network's RXRX Position: Q1 2026 in Review

Advisory Services Network reduced its Recursion Pharmaceuticals (RXRX) stake by 10% in Q1 2026, selling an estimated $4.06K and leaving 9,461 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #2964.

Advisory Services Network first reported a position in RXRX in Q4 2022 and has held it in 9 quarters since. The position peaked at $74K in Q4 2024. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

• Advisory Services Network held 9,461 shares of Recursion Pharmaceuticals worth $29K as of Q1 2026.
• Advisory Services Network sold 1,050 Recursion Pharmaceuticals shares in Q1 2026, an estimated $4.06K.
• Recursion Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #2964 holding.
• Advisory Services Network first reported a position in Recursion Pharmaceuticals in Q4 2022 and has held it in 9 quarters since.
• Advisory Services Network's Recursion Pharmaceuticals position peaked at $74K in Q4 2024.
• 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.